Beijing Kangleweishi Biotechnology Co.
Latest round
- Series A
Last raised
- Sep 2008
Total raised
- $2.2M
Investors
- 1
About Beijing Kangleweishi Biotechnology Co.
, trading under the name Heath Guard, provides a platform for the development of recombinant protein drugs. The company was listed under the name Kangle Guardian in National SME Share Transfer System in 2015., Ltd., Yingke Private Equity, and Yufeng Capital. The company's platform offers research and development of recombinant protein drugs and offers the development of HPV poly-vaccine. The platform helps to develop recombinant trivalent human papillomavirus (HPV) vaccine and a recombinant nine-valent HPV vaccine to prevent cervical cancer, a recombinant 15-valent HPV vaccine, a recombinant hand-foot-mouth disease (EV71/CoX A16 virus) vaccine, a recombinant Norovirus (NoV) vaccine and human parathyroid hormone (rh-PTH) and other biological products for prevention and treatment. The company plans to expedite clinical trials of vaccines, expand its research and development to include hand-foot-and-mouth disease, norwalk virus, poliovirus, herpes zoster, influenza, and COVID-19, among others.
Who invested in Beijing Kangleweishi Biotechnology Co.
1 investor across 1 round
See all investors in Beijing Kangleweishi Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 2, 2008
Amount
$2.2M
Investors
Questions about Beijing Kangleweishi Biotechnology Co.
Who invested in Beijing Kangleweishi Biotechnology Co.?
Beijing Kangleweishi Biotechnology Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Kangleweishi Biotechnology Co. raised?
Beijing Kangleweishi Biotechnology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Beijing Kangleweishi Biotechnology Co. last raise money?
Beijing Kangleweishi Biotechnology Co.'s most recent round on record is a Series A, in Sep 2008.
What does Beijing Kangleweishi Biotechnology Co. do?
, trading under the name Heath Guard, provides a platform for the development of recombinant protein drugs.
Where is Beijing Kangleweishi Biotechnology Co. headquartered?
Beijing Kangleweishi Biotechnology Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Kangleweishi Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Kangleweishi Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Beijing Kangleweishi Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.